Can a 5-Day proton blast beat prostate cancer for good?

NCT ID NCT07699705

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study follows 50 men with localized prostate cancer who received a very short course of high-dose proton beam therapy (just 5 sessions). Researchers want to see how well this treatment controls cancer over the long term and what factors predict success or side effects. Participants will complete quality-of-life questionnaires and have regular checkups to track recurrence and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ultrahypofractionated proton beam therapy
What this could lead to
If successful, this could help identify which patients benefit most from this precise, short-course radiation therapy, potentially improving treatment planning and reducing side effects.
What could go wrong
This is an observational study with only 50 participants, so results may not apply to all patients. Long-term outcomes are still unknown, and side effects from radiation remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Cancer Center, Korea

    RECRUITING

    Goyang-si, Gyeonggi-do, 10408, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.